cytokinetics inc (CYTK:NASDAQ CM)

Executive Profile*

Background*

Mr. Robert I. Blum has been the Chief Executive Officer of Cytokinetics, Incorporated. since January 2007, President since February 9, 2006and it's Chief Executive of the Biopharmaceutical Concern since January 22, 2007. Mr. Blum has been with Cytokinetics in July 1998. He served as an Executive Vice President for Corporate Development and Commercial Operations and Chief Business Officer of Cytokinetics, Incorporated from September 15, 2004 to February 2006. Mr. Blum ... served as the Principal Accounting Officer of Cytokinetics, Incorporated until September 2004 and served as its Secretary. Mr. Blum served as Chief Financial Officer of Cytokinetics, Incorporated. since October 2001 until September 2004. Mr. Blum served as an Executive Vice President for Corporate Development and Finance of Cytokinetics Incorporated from January 2004 to September 2004. From September 2001 to September 2004, he served as the Chief Financial Officer of Cytokinetics, Incorporated. From October 2001 to December 2003, he served as Senior Vice President for Corporate Development and Finance of Cytokinetics, Incorporated. From July 1998 to September 2001, Mr. Blum served as Vice President for Business Development of Cytokinetics, Incorporated. Mr. Blum served as Director of Marketing at COR Therapeutics, Inc., a biopharmaceutical company since 1996. From 1991 to 1996, he served as Director of Business Development at COR Therapeutics. Mr. Blum held various sales, marketing and other pharmaceutical business roles of increasing responsibility at Marion Laboratories, Inc. and Syntex Laboratories, Inc. He has been a Director of Cytokinetics, Incorporated. since January 22, 2007. Mr. Blum holds a BA degree in Human Biology and Economics from Stanford University and an MBA from Harvard Business School.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
CYTK:US	$1.16 USD	-0.04

COMPETITOR COMPENSATION